by Elec23 | Feb 24, 2025 | News&events
VisMederi has expanded its testing portfolio with cutting-edge pseudo-viral platforms, which are critical tools for examining immunogenicity and developing vaccines against emerging infections. These new technologies enable us to test immune responses in a safe and...
by Elec23 | Aug 7, 2024 | News&events
VisMederi has been successfully qualified by Qualifyze for conducting activities according to GCLP (Good Clinical Laboratory Practices). Both our laboratory facilities have achieved the prestigious SILVER rating! This outstanding result once again reflects our utmost...
by sara pugliese | Jan 18, 2016 | News&events
The Tuscany Region financed three innovative R&D projects involving VisMederi. The winning ideas, Magic- Theravax, Inside and Innoviral, are among the 138 projects presented by small, medium and large enterprises that the Region funded for a total of over 40...
